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Mitochondrial cytopathies are a group of disorders marked by a characteristic clinical phenotype, maternal pattern of inheritance, muscle fibers that contain increased numbers of mitochondria or structurally abnormal mitochondria, and abnormalities of oxidative phosphorylation enzymes often associated with mutations in mitochondrial DNA. [1] [2] [3] [4] [5] [6] [7] The diagnosis of mitochondrial disorders is often predicated on the evaluation of a number of different parameters, including clinical evaluation of the patient, biochemical assays of oxidative phosphorylation activity and/or enzyme activity, laboratory data suggestive of a disorder of oxidative metabolism (lactic acidosis, citric acid cycle intermediates, or organic acid analysis), muscle or skin biopsies, and molecular biologic studies to assess for specific mitochondrial DNA mutations. The role of muscle biopsy in the evaluation of such cases is well recognized. The diagnostic yield of such specimens, however, is less clear. Certain pathologic findings are associated with mitochondrial derangements, most particularly ragged red fibers and an absence of cytochrome oxidase staining in myofibers. These routine light microscopic observations are present only variably. Electron microscopic evaluation may reveal increased mitochondrial number or abnormalities in mitochondrial structure. These ultrastructural findings may not necessarily be present in all cases.
We retrospectively reviewed 118 muscle biopsy specimens from 113 patients clinically suspected of having mitochondrial cytopathy. Specific attention was given to the light microscopic and ultrastructural yield of the biopsy specimen in the evaluation of such cases. We also examined the additional diagnostic usefulness of skin biopsies in the assessment of this disorder.
Materials and Methods
We searched the surgical pathology files of 263 patients who were seen at the Cleveland Clinic, Cleveland, OH, during a 10-year period (June 1990-June 2000) and were suspected of having a mitochondrial cytopathy. Clinical and laboratory criteria used to classify patients included the following: (1) at least 3 signs and symptoms in at least 2 organ systems known to be seen as part of a classic mitochondrial syndrome; (2) supporting laboratory evidence, including elevated cerebrospinal fluid or plasma lactic acid level, abnormal organic acid patterns, elevated plasma alanine level, generalized amino aciduria, carnitine deficiency, or excessive excretion of urinary acylcarnitines; and (3) exclusion, when possible, of other disorders that could mimic mitochondrial cytopathy. During the aforementioned period, 113 patients in this group underwent muscle biopsy. Two patients underwent 2 biopsies each, and 1 patient underwent 4 muscle biopsies. In each case, all available light microscopic materials and pathology reports were reviewed, as were electron microscopic materials and reports. For all but 2 muscle biopsy specimens, a full complement of enzyme histochemical and special stains were reviewed, including H&E, nicotinamide adenosine dinucleotide (NADH)-tetrazolium reductase, Gomori trichrome, periodic acid-Schiff (PAS), adenosine triphosphatase at pH 4.6 and 9.8, nonspecific esterase, oil red O, acid phosphatase, alkaline phosphatase, cytochrome oxidase, and sulfonated alcian blue. For each case, light microscopic abnormalities were noted when present. Particular attention was given to features that may indicate a mitochondrial abnormality, including ragged red fibers on the Gomori trichrome stain and cytochrome oxidase-deficient fibers.
Electron micrographs were available for independent review by 2 authors (R.A.P., J.T.M.) for all but 5 muscle biopsy specimens (n = 113). Structural abnormalities were documented when present. Again, particular attention was given to abnormalities that may indicate a mitochondrial defect, including increased numbers of mitochondria, increased mitochondrial size, and presence of paracrystalline mitochondrial inclusions.
In addition, the pathology files of the 113 patients who underwent a muscle biopsy were searched for evidence of a concomitant skin biopsy; 39 were found. Electron micrographs were available for review in all 39 cases and abnormalities noted when present, with particular attention given to whether mitochondrial defects were present.
Results
The study group included 118 muscle biopsy specimens from 113 patients. Patients included 65 females (57.5%) and 48 males (42.5%). At the time of biopsy, the patients ranged in age from 1 month to 70 years (mean, 12.5 years). The most commonly biopsied sites included the left quadriceps (n = 22); left thigh region, not otherwise specified (n = 20); left vastus lateralis (n = 15); right quadriceps (n = 13); and right thigh region, not otherwise specified (n = 10).
❚Table 1❚ summarizes the salient light microscopic and electron microscopic findings in muscle. By light microscopic evaluation, 53 biopsy specimens (44.9%) were normal. Ragged red fibers were identified on the Gomori trichrome stain in only 3 biopsy specimens (2.5%) ❚Image 1❚. In each of these cases, the number of ragged red fibers constituted less than 10% of the total number of fibers on the biopsy. In 8 cases (6.8%), cytochrome oxidase-deficient fibers were observed ❚Image 2❚. The number of cytochrome oxidase-deficient fibers was less than 2% of the fibers examined in each of the muscle biopsy specimens.
Other light microscopic abnormalities included the presence of scattered angular atrophic esterase-positive myofibers, indicative of acute neurogenic atrophy, in 30 biopsy specimens (25.4%). Type II muscle fiber atrophy was identified in 18 specimens (15.3%) and type I fiber atrophy in 3 (2.5%). Fiber type grouping, indicative of chronic neurogenic atrophy, was noted in 2 specimens (1.7%). Motheaten fibers were identified in 3 fibers on the NADH stain (2.5%) and targetoid fibers on the same stain in 3 cases (2.5%). Regenerating muscle fibers, highlighted with the alkaline phosphatase stain, were identified in 8 biopsy specimens (6.8%), and rare degenerating muscle fibers, highlighted with acid phosphatase, were observed in 4 biopsy specimens (3.4%). Increased myofiber lipid was observed in 2 biopsy specimens (1.7%) with the oil red O stain, and increased glycogen was evident on the PAS stain in 1 biopsy specimen (0.8%). In 7 biopsy specimens, rare small foci of chronic endomysial and perivascular inflammation consisting primarily of lymphocytes were identified (5.9%). Ultrastructural evaluation of 113 muscle biopsy specimens revealed normal morphologic features in 34 cases (30.1%). Increased numbers of mitochondria, particularly in the subsarcolemmal region, were identified in 54 biopsy specimens (47.8%). In 8 biopsy specimens, increased mitochondrial size was identified (7.1%). Paracrystalline mitochondrial inclusions were identified in 3 biopsy specimens (2.7%) ❚Image 3❚, including specimens from 2 of the patients who had ragged red fibers on trichrome staining and 1 patient who had cytochrome oxidase-deficient fibers. Of the 53 muscle biopsy specimens that were normal by light microscopic examination, 35 (66%) demonstrated some ultrastructural abnormality.
Additional ultrastructural findings included the presence of focal Z-band streaming in scattered myocytes in 10 cases (8.8%), increased lipid accumulation in 9 specimens (8.0%), and increased glycogen material in 13 specimens (11.5%). Concentric laminated bodies were noted in 2 biopsy specimens (1.8%). Tubulofilamentous structures measuring 12 to 15 nm in diameter were identified in 1 specimen (0.9%). Other stigmata of inclusion body myositis were not noted in this patient's biopsy specimen. Rare autophagic vacuoles were identified in 2 specimens (1.8%). One patient (0.9%) had a focus of macrophages in what otherwise looked like normal-appearing muscle. The nature of this inflammatory response is uncertain.
Thirty-nine of the 113 patients also underwent concomitant axillary skin biopsy. Of this group, 27 of the axillary skin biopsy specimens were normal by ultrastructural evaluation. The remaining 12 specimens showed a variety of pathologic findings, including atypical mitochondria in sweat duct and glandular epithelium in 7 cases, increased mitochondrial number in 6 cases, increased lipid accumulation in 1 case, and increased glycogen deposition in 1 case.
Discussion
Ragged red fibers are the most cited light microscopic feature associated with the mitochondrial cytopathies. This finding is best demonstrated on frozen muscle sections stained with a Gomori trichrome stain and is characterized by the subsarcolemmal collection of eosinophilic staining, granular material corresponding to an accumulation of diseased mitochondria. Although the finding is most classically associated with mitochondrial myopathy, ragged red fibers have been described rarely in association with other muscle pathologies, including normal aging. [8] [9] [10] [11] [12] In general, mitochondrial cytopathies are associated with greater numbers of ragged red fibers than are other processes in which such fibers may be found. 13 The incidence of ragged red fibers in a cohort of patients with clinical mitochondrial myopathy is not well documented in the literature. Johnston et al, 1 in a series of 9 patients with late-onset mitochondrial ❚Image 1❚ Increased peripheral red staining mitochondria (ragged red fiber) (Gomori trichrome stain, original magnification ×400).
❚Image 2❚ Cytochrome oxidase-negative myofiber (cytochrome oxidase, original magnification ×400).
myopathy (older than 59 years), found ragged red fibers in all 9. In the present series, only 3 biopsy specimens (2.5%) showed obvious ragged red fiber formations. Differences may be related, in part, to how one defines the ragged red fiber and the extent of the subsarcolemmal staining one needs to see before making the diagnosis. In the present series, a rather stringent definition was used; only fibers in which more than 50% of the circumference was rimmed by subsarcolemmal eosinophilic staining material on the trichrome stain were designated as a ragged red fiber. The percentage of myofibers, which are ragged red fibers in a given muscle biopsy specimen, shows marked variability and has ranged in the literature anywhere from less than 1% to 70% of the total fibers. 1, 12, 14 In all 3 of the cases in the present series, ragged red fibers constituted less than 5% of the total number of myofibers examined. Some have advocated looking for socalled ragged blue fibers on succinate dehydrogenase staining as indicative of mitochondrial disease. 13 Reichmann et al 13 found that the identification of ragged red fibers on a trichrome stain was more specific for mitochondrial cytopathy than the identification of ragged blue fibers.
Cytochrome oxidase-deficient myofibers also have been described as a histologic feature characterizing a subset of mitochondrial myopathies. Cytochrome oxidase-negative myofibers are almost invariably present in patients with progressive external ophthalmoplegia and Kearns-Sayre syndrome and may be found in a subset with other mitochondrial encephalomyopathies and in those with myopathy alone. 12 There is some suggestion that loss of cytochrome oxidase activity may correlate with disease progression. 15, 16 Similar to ragged red fibers, loss of cytochrome oxidase activity may be segmental and not involve the entire length of the myofiber. Similar to ragged red fibers, the presence of cytochrome oxidase-deficient myofibers is a variable finding. In a series of 35 muscle biopsy specimens examined to evaluate mitochondrial pathology, cytochrome oxidase-deficient myofibers were seen in only 1 case. 17 In the present series, cytochrome oxidase-deficient myofibers were noted in 8 biopsy specimens (6.8%). In each of these cases, the number of cytochrome oxidase-deficient fibers represented less than 5% of the total number of myofibers examined. In the present study, the presence of cytochrome oxidase-deficient fibers was observed somewhat more commonly than ragged red fibers.
Other changes associated with mitochondrial cytopathies include the presence of increased lipid and glycogen material. This was detected by light microscopic evaluation using PAS and oil red O stains in 1 and 2 cases, respectively. Ultrastructural evaluation of the muscle was more sensitive in this regard; 13 biopsy specimens (11.5%) were noted to have increased glycogen deposition, and 9 biopsy specimens (8.0%) had increased lipid deposition. The most common light microscopic abnormalities observed included the presence of rare, angular atrophic esterase-positive muscle fibers, indicative of denervative atrophy in 25% of cases and type II muscle fiber atrophy in 15% of cases. In most of the biopsy specimens in which angular atrophic esterase-positive muscle fibers were observed, these fibers were present in very low numbers and probably were not indicative of clinically significant disease. In 2 cases, this finding was accompanied by fiber type grouping suggesting a true neurogenic atrophy. The prominent presence of type II muscle atrophy in a subset of patients may represent a form of disuse atrophy.
In contrast with the small number of biopsy specimens in which the light microscopic findings were suggestive of a mitochondrial defect (cytochrome oxidase-deficient myofibers or ragged red fibers were observed), more than 50% showed some ultrastructural evidence of mitochondrial abnormalities. Parallel to the presence of ragged red fibers, ultrastructural changes of mitochondria have been described in a wide variety of other muscle disorders, including muscular dystrophies, neurogenic atrophy, inflammatory myopathies, and acid maltase deficiency. [18] [19] [20] [21] [22] In most of these cases, the other pathologic abnormalities that characterize these conditions overshadow the ultrastructural findings. The most common ultrastructural abnormality related to mitochondria in the present series included an increased number of mitochondria. This finding was observed in nearly half of the biopsy specimens. Less commonly, dysmorphic mitochondrial features were noted, including increase in mitochondrial size (n = 8 [7. 1%]) and paracrystalline mitochondrial inclusions (n = 3 [2.7%]). It would seem that not all patients with defects of mitochondrial metabolism will have ultrastructural evidence of muscle ❚Image 3❚ Increased number of mitochondria with paracrystalline inclusions (original magnification ×17,000).
Downloaded from https://academic.oup.com/ajcp/article-abstract/116/3/326/1758113 by guest on 07 April 2018 © American Society of Clinical Pathologists mitochondrial abnormalities. In general, defects of mitochondrial proliferation and structural changes of mitochondria seem to be more common in disorders involving the respiratory chain and coupling of oxidative phosphorylation as opposed to substrate utilization. 6 In the series of 35 biopsy specimens evaluated by Letellier and colleagues, 17 ultrastructural abnormalities of mitochondria were observed in 5 cases (14%). Thus far, no clear correlations between mitochondrial ultrastructural findings and clinical phenotype or specific DNA mutational changes have been made. 6, 12 Thirty-nine of the 113 patients who underwent muscle biopsy also underwent concomitant skin biopsy. Ultrastructural evaluation of the skin biopsy specimens in the majority of cases was normal. In 12 specimens, a variety of abnormalities were noted, including increased numbers of mitochondria, morphologically atypical mitochondria, and an accumulation of lipid and glycogen deposition. Presumably these findings are in keeping with those of a mitochondrial cytopathic process. All patients who had increased numbers of mitochondria or atypical mitochondria in the skin biopsy specimen also had similar ultrastructural findings. While the diagnostic yield may be somewhat lower for skin biopsy evaluation, the procedure nevertheless may prove useful for helping to establish the diagnosis. The less invasive nature of the skin biopsy also may prove more attractive, particularly in pediatric-aged patients. Skin biopsy also may permit identification of other metabolic conditions that may mimic mitochondrial diseases.
Although a subset of patients with mitochondrial cytopathies may not have obvious evidence of morphologic abnormalities by light or electron microscopic evaluation, it seems that the majority of patients have some finding that may indicate such abnormality exists. Recognition of such findings can be useful for further directing the evaluation of these patients. The diagnosis of mitochondrial cytopathy often rests on the clinical parameters and manifestations. Biopsy findings often serve only to corroborate the clinical impression, since the light and electron microscopic findings suggestive of a mitochondrial abnormality may be encountered in a variety of other muscular disorders (such as inclusion body myositis) and may even be encountered in "normal" elderly people. Obtaining muscle tissue also may provide material for more definitive evaluation using molecular biologic techniques to demonstrate specific mitochondrial DNA mutations or for evaluating specific mitochondrial enzyme function.
